One Month To Go until the Switch from Trivalent to Bivalent Oral Polio Vaccine

There is now one month to go until the globally synchronised project in the history of vaccination: the removal of the type two component of the oral polio vaccine

201602322_1monthtogo_Switch
Bivalent oral poliovirus vaccine is being delivered to all 155 OPV-using countries. ©UNICEF

Between 17 April and 1 May, every country in the world currently using oral poliovirus vaccine (OPV) must withdraw the trivalent vaccine (tOPV) and replace it with the bivalent vaccine (bOPV). This will continue to protect infants from poliovirus types 1 and 3 while withdrawing the type 2 component, thereby mitigating the risk of seeding new type 2 circulating vaccine-derived poliovirus (cVDPV2).

With less than a month to go, countries are demonstrating strong progress towards readiness for the switch.

All 155 countries that use OPV have now developed switch plans and are putting the final preparations in place. Nearly 75% of the countries (112) have already received their shipments of bOPV, which are being distributed to peripheral storage location and service points.  The GPEI have provided financial support to 67 countries to aid planning and implementation, 43 of are high risk and low income countries.

In the final run-up, switch monitors are being trained to ensure the switch is overseen in an effective way to ensure that no single health facility or vaccine storage centre continues to store or use stocks of trivalent OPV after the switch date. Global monitors have been designated to 27 countries from the US Centres for Disease Control and Prevention, the Bill and Melinda Gates Foundation, the Task Force on Global Health, UNICEF, Rotary International and WHO. Other in-country immunization-partners are deploying extra staff to the field.

Watch this series of short videos to understand more about the polio vaccines, the phased withdrawal of the oral polio vaccine starting with the switch and other steps being taken to secure a polio-free world.

With careful planning and thorough oversight, the switch will represent a huge achievement for the polio programme and will provide a basis for the eventual withdrawal of all OPV, following eradication of poliovirus types 1 and 3.

Read more about preparations for the switch here.


Related News

   25/01/2023
This snapshot shows all polio events and outbreaks that occurred/were ongoing in the Eastern Mediterranean Region (EMR) in 2022
   24/01/2023
Polio programme must keep clear focus in 2023 on adapting operations amid broader humanitarian emergencies
   16/01/2023
This is the target year for interrupting all remaining poliovirus transmission globally, both in the remaining endemic countries and in outbreak settings.
   12/01/2023
Dr Hamid Jafari, Director of Polio for the WHO’s Eastern Mediterranean Region, reflects on his time eradicating polio in India and what lessons we can take from this to address the final challenges for achieving eradication in Afghanistan and Pakistan.
   03/01/2023
When a mother brought her young son to a clinic in Paghman, a town not far from the Afghan capital Kabul, Spogmai, a nurse on duty at the time, paid special attention.
   19/12/2022
Recommendations from the international review of Afghanistan’s poliovirus surveillance system are yielding important results for the country’s eradication programme.